Why is 3B Blackbio falling/rising?

As of 28-Jul, 3B Blackbio DX Ltd is experiencing a rise in its stock price, currently at 1,506.50, reflecting an increase of 58.5 or 4.04%. Today's price summary indicates that the stock outperformed its sector by 3.82%, reaching an intraday high of Rs 1550, which is a 7.04% increase, although it also saw a low of Rs 1402.05, marking a decline of 3.17%. Over the past year, the stock has generated a return of 42.09%, significantly outperforming the BSE500 index, and has shown consistent returns over the last three years. However, the company has faced challenges, including flat results in March 2025, with the lowest PBDIT and operating profit margins, which may contribute to investor caution despite its healthy long-term growth and low debt-to-equity ratio.
In the broader market context, the stock's short-term performance over the past week shows a decline of 3.12%, while the benchmark Sensex has decreased by 1.59%, indicating that the stock is underperforming relative to the market in the short term. However, in the longer term, the stock has outperformed the benchmark with a 5.57% gain over the past month compared to the Sensex's decline of 3.77%. The rising investor participation, evidenced by a significant increase in delivery volume, suggests growing interest in the stock, which may be a positive sign for its future performance despite the current volatility and mixed financial indicators.